Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer
- Heba Alkhatib
- , Jason Conage-Pough
- , Sangita Roy Chowdhury
- , Denen Shian
- , Deema Zaid
- , Ariel M. Rubinstein
- , Amir Sonnenblick
- , Tamar Peretz-Yablonsky
- , Avital Granit
- , Einat Carmon
- , Ishwar N. Kohale
- , Judy C. Boughey
- , Matthew P. Goetz
- , Liewei Wang
- , Forest M. White*
- , Nataly Kravchenko-Balasha*
*Corresponding author for this work
- Hebrew University of Jerusalem
- Massachusetts Institute of Technology
- Tel Aviv Sourasky Medical Center
- Hadassah University Medical Centre
- Assuta Ashdod Hospital
- Mayo Clinic Rochester, MN
- Mayo Clinic College of Medicine and Science
Research output: Contribution to journal › Letter › peer-review
15
Scopus
citations